BioSpace News Archive

Biotech Bay

Fauna Bio Researcher Awarded NASA Early-Stage Grant to Study Hibernation in Space

Fauna Bio, a biotechnology company that leverages animal genomics to improve human health, announces Senior Research Physiologist Ryan Sprenger, Ph.D., has been awarded a NASA Innovative Advanced Concepts grant.

January 22, 2024
·
4 min read
FDA

Thirona receives FDA 510(k) Clearance for LungQ v3.0.0 Software to Power AI Analysis of Chest CT Images

Thirona announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest update of its AI-based clinical software LungQ™ (v3.0.0).

January 22, 2024
·
3 min read
Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024.

January 22, 2024
·
8 min read
Business

RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors

RespireRx Pharmaceuticals Inc. is pleased to announce the appointment of Dr. Dariusz Nasiek MD, MBA to its board of directors.

January 22, 2024
·
13 min read
Genetown

MitoSense Inc. Completes $3.5 Million Series Seed Funding Round, Led by Caydan Capital Partners

MitoSense Inc. announces the successful closure of its Series Seed Funding Round led by Caydan Capital Partners, raising close to $3.5 million.

January 22, 2024
·
2 min read
Business

Single Pass and Mermaid Medical Group Announce Exclusive US Distribution Deal for Biopsy Closure Device

Single Pass, a leading provider of innovative medical devices, is pleased to announce an exclusive distribution agreement with Mermaid Medical Group, a renowned global medical technology company.

January 22, 2024
·
3 min read
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID

Virios Therapeutics, Inc. today announced plans for advancing IMC-2 (combination of valacyclovir and celecoxib) as a treatment for the fatigue, orthostatic intolerance and other symptoms associated with LC, also known as post-acute sequelae of SARS-CoV-2 infection (“PASC”).

January 22, 2024
·
4 min read
Deals

MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger (NASDAQ: COCH)

MCRA, LLC is pleased to announce its role in providing strategic due diligence support for Anzu Special Acquisition Corp I, ahead of the recent deal with Envoy Medical .

January 22, 2024
·
5 min read
Business

John Ratliff Appointed Chief Executive Officer of Premier Research

Premier Research announced the appointment of John Ratliff to the position of Chief Executive Officer and Board member.

January 22, 2024
·
2 min read
Defence Financing

Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (“Defence” or the “Company”), one of the leading Canadian biotechnology companies working in the field of immune-oncology announces, further to its news release on January 12, 2024, an amendment on the financing.

January 22, 2024
·
3 min read